[Federal Register Volume 80, Number 120 (Tuesday, June 23, 2015)]
[Notices]
[Pages 35990-35991]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15391]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2015-0020]


Information Collection: NRC Request for Sodium Iodide I-131 
Treatment and Patient Release Information

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of submission to the Office of Management and Budget; 
request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a proposed collection of information to the Office of 
Management and Budget (OMB) for review. The information collection is 
entitled, ``NRC Request for Sodium Iodide I-131 Treatment and Patient 
Release Practices.''

DATES: Submit comments by July 23, 2015.

ADDRESSES: Submit comments directly to the OMB reviewer at: Vlad 
Dorjets, Desk Officer, Office of Information and Regulatory Affairs, 
(3150-XXXX), NEOB-10202, Office of Management and Budget, Washington, 
DC 20503; telephone: 202-395-7315, email: [email protected].

FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, NRC Clearance 
Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; 
telephone: 301-415-6258; email: [email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC 2015-0020 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC 2015-0020. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC 2015-0020 on this Web site.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. The 
supporting statement and Patient Release Federal Register Notice (FRN) 
Soliciting Information is available in ADAMS under Accession No. 
ML15134A123.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting the NRC's Clearance Officer, Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
[email protected].

B. Submitting Comments

    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC posts all comment submissions at http://www.regulations.gov as well as entering the comment submissions into 
ADAMS. The NRC does not routinely edit comment submissions to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment submissions into ADAMS.

II. Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44 
U.S.C. chapter 35), the NRC recently submitted a proposed collection of 
information to OMB for review entitled, ``NRC Request for Sodium Iodide 
I-131 Treatment and Patient Release Practices.'' The NRC hereby informs 
potential respondents that an agency may not conduct or sponsor, and 
that a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.
    The NRC published an FRN with a 60-day comment period on this 
information collection on March 3, 2015; 80 FR 11471, entitled ``NRC 
Request for Sodium Iodide I-131 Treatment and Patient Release 
Practices.''
    1. The title of the information collection: ``NRC Request for 
Sodium Iodide I-131 Treatment and Patient Release Practices.''
    2. OMB approval number: An OMB control number has not yet been 
assigned to this proposed information collection.
    3. Type of submission: New.
    4. The form number if applicable: Not Applicable.
    5. How often the collection is required or requested: Once.
    6. Who will be required or asked to respond: Medical professional 
organizations, physicians, patients, patient advocacy groups, NRC and 
Agreement State medical use licensees, Agreement States, and other 
interested individuals who use, receive, license or have interest in 
the use of I-131 sodium iodide (hereafter referred to as ``I-131'') for 
the treatment of thyroid conditions.

[[Page 35991]]

    7. The estimated number of annual responses: A one-time collection 
estimated to have 1,180 responses (620 medical community + 560 
patients).
    8. The estimated number of annual respondents: 1,180 respondents 
(620 medical community + 560 patients).
    9. An estimate of the total number of hours needed annually to 
comply with the information collection requirement or request: 457.5 
hours (255 medical community + 202.5 patients).
    10. Abstract: The NRC is requesting a one-time information 
collection that will be solicited in an FRN. The FRN will have specific 
I-131 patient release questions associated with: (1) Existing Web sites 
that the responders believe provide access to clear and consistent 
patient information about I-131 treatment processes and procedures; (2) 
information the responders believe represent best practices used in 
making informed decisions on releasing I-131 patients and stand alone 
or supplemental voluntary patient/licensee guidance acknowledgment 
forms, if available; (3) an existing set of guidelines that the 
responder developed or received that provides instructions to released 
patients; and (4) an existing guidance brochure that the responder 
believes would be acceptable for nationwide distribution. The responses 
will form the basis for patient release guidance products developed in 
response to the NRC's April 28, 2014, Staff Requirements--COMAMM-14- 
0001/COMWDM-14-0001--``Background and Proposed Direction to NRC Staff 
to Verify Assumptions Made Concerning Patient Release Guidance.'' The 
Commission, based on information from patients and patient advocacy 
groups, questioned the availability of clear, consistent, patient 
friendly and timely patient release information and directed the staff 
to work with a wide variety of stakeholders when developing new 
guidance products. This information collection effort was developed to 
gain input from as many stakeholders as possible. The NRC solicitation 
in the Federal Register is to obtain existing information from a 
variety of stakeholders.

    Dated at Rockville, Maryland, this 18th day of June, 2015.

    For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information Services.
[FR Doc. 2015-15391 Filed 6-22-15; 8:45 am]
BILLING CODE 7590-01-P